MOLECULAR PHARMACOLOGY (USA) LTD. Increase (Decrease) in Accounts Receivable
MOLECULAR PHARMACOLOGY (USA) LTD. reported Increase (Decrease) in Accounts Receivable of -$834 for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2014-11-13
- MOLECULAR PHARMACOLOGY (USA) LTD. increase (decrease) in accounts receivable for the quarter ending 2014-09-30 was -$834.00.
- MOLECULAR PHARMACOLOGY (USA) LTD. increase (decrease) in accounts receivable for the quarter ending 2013-09-30 was -$353.00.
- MOLECULAR PHARMACOLOGY (USA) LTD. increase (decrease) in accounts receivable for fiscal 2014 was -$1.42K, a 3657.50% decline from fiscal 2013.
- MOLECULAR PHARMACOLOGY (USA) LTD. increase (decrease) in accounts receivable for fiscal 2013 was $40.00, a 97.33% decline from fiscal 2012.
- MOLECULAR PHARMACOLOGY (USA) LTD. increase (decrease) in accounts receivable for fiscal 2012 was $1.50K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 120 month | Increase (Decrease) in Accounts Receivable 123 month |
|---|---|---|---|---|
| 2014-09-30 | -$834.00 10-Q · filed 2014-11-13 | -$5.10K 10-Q · filed 2014-11-13 | ||
| 2014-06-30 | -$1.42K 10-K · filed 2014-09-08 | -$4.27K 10-K · filed 2014-09-08 | ||
| 2013-09-30 | -$353.00 10-Q · filed 2014-11-13 | |||
| 2013-06-30 | $40.00 10-K · filed 2014-09-08 | |||
| 2012-06-30 | $1.50K 10-K · filed 2014-09-08 |